Semler Scientific (SMLR)
(Delayed Data from NSDQ)
$26.11 USD
+0.20 (0.77%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $25.98 -0.13 (-0.50%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Semler Scientific Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 57 | 43 | 37 | 22 | 8 |
Receivables | 6 | 4 | 4 | 3 | 3 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 1 | 0 | 0 |
Other Current Assets | 2 | 1 | 4 | 1 | 0 |
Total Current Assets | 66 | 49 | 46 | 26 | 11 |
Net Property & Equipment | 1 | 1 | 0 | 0 | 0 |
Investments & Advances | 6 | 6 | 1 | 3 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 3 | 2 | 2 | 2 | 5 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 0 | 3 | 0 | 0 | 0 |
Total Assets | 78 | 63 | 51 | 35 | 18 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 0 | 1 | 0 | 1 | 0 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 5 | 5 | 3 | 3 | 4 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 1 | 1 | 1 | 1 | 1 |
Total Current Liabilities | 6 | 7 | 5 | 5 | 5 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 6 | 7 | 5 | 5 | 5 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 12 | 16 | 21 | 22 | 19 |
Retained Earnings | 60 | 39 | 25 | 8 | -6 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 72 | 56 | 46 | 30 | 13 |
Total Liabilities & Shareholder's Equity | 78 | 63 | 51 | 35 | 18 |
Total Common Equity | 72 | 56 | 46 | 30 | 13 |
Shares Outstanding | 6.80 | 6.80 | 6.70 | 6.70 | 6.50 |
Book Value Per Share | 10.56 | 8.19 | 6.80 | 4.45 | 2.01 |
Fiscal Year End for Semler Scientific Inc falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 57 | 56 | 52 | 43 |
Receivables | NA | 6 | 6 | 6 | 9 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 0 | 0 | 0 | 1 |
Other Current Assets | NA | 2 | 2 | 2 | 3 |
Total Current Assets | NA | 66 | 64 | 61 | 56 |
Net Property & Equipment | NA | 1 | 1 | 1 | 1 |
Investments & Advances | NA | 6 | 6 | 6 | 6 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 3 | 3 | 3 | 2 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 3 | 3 | 3 |
Total Assets | NA | 78 | 79 | 75 | 70 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 0 | 0 | 1 | 0 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 5 | 7 | 8 | 7 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 1 | 1 | 1 | 1 |
Total Current Liabilities | NA | 6 | 9 | 10 | 9 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 6 | 9 | 10 | 9 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 12 | 15 | 15 | 17 |
Retained Earnings | NA | 60 | 56 | 50 | 44 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 72 | 71 | 65 | 61 |
Total Liabilities & Shareholder's Equity | NA | 78 | 79 | 75 | 70 |
Total Common Equity | 0 | 72 | 71 | 65 | 61 |
Shares Outstanding | 7.00 | 6.80 | 6.80 | 6.80 | 6.80 |
Book Value Per Share | 0.00 | 10.56 | 10.41 | 9.60 | 9.00 |